How much did CeleCor Therapeutics, Inc. raise?

CeleCor Therapeutics, Inc. raised $1 Million in a Seed round on May 10, 2021.

Where is CeleCor Therapeutics, Inc. based and how big is it?

CeleCor Therapeutics, Inc. is based in Del Mar, California, United States. Fundz records about 4 employees.

Who are the decision-makers at CeleCor Therapeutics, Inc?

Fundz holds 2 contacts at CeleCor Therapeutics, Inc., including the Chief Financial Officer. Names and contact details are shown to Fundz members.

Cele Cor Therapeutics, Inc. reported raising $1 Million in an initial SEC Form D filing, from an offering of $5 Million

PRIVATEMay 10, 2021$1M of $5M raised

Amount Raised

$1 Million

$1 Million sold, per SEC Form D (first sale May 10, 2021)

Round Type

Seed

Del MarBiotechnology

Quick answer

CeleCor Therapeutics, Inc. raised $1 Million in a Seed round, dated May 10, 2021. CeleCor Therapeutics, Inc. is based in Del Mar, California, United States.

How much did CeleCor Therapeutics, Inc. raise?: CeleCor Therapeutics, Inc. raised $1 Million in a Seed round on May 10, 2021.
What does CeleCor Therapeutics, Inc. do?: CeleCor Therapeutics is a biotechnology company on a mission to develop therapies that will get patients with a heart attack to the hospital with open coronary arteries.
Where is CeleCor Therapeutics, Inc. based and how big is it?: CeleCor Therapeutics, Inc. is based in Del Mar, California, United States. Fundz records about 4 employees.
Who are the decision-makers at CeleCor Therapeutics, Inc?: Fundz holds 2 contacts at CeleCor Therapeutics, Inc., including the Chief Financial Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as CeleCor Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

Myrtelle raised $14M on June 24, 2021.
Umoja Biopharma raised $210M on June 24, 2021.
NeuSpera Medical raised $66M on June 24, 2021.
Lyndra Therapeutics, Inc. raised $61M (Series C) on June 24, 2021.
Glycomine, Inc. raised $68M (Series B) on June 23, 2021.
STRAND THERAPEUTICS INC raised $52M (Series A) on June 23, 2021.

Who to call at CeleCor Therapeutics, Inc., and when

A new round usually means CeleCor Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

An alert the day CeleCor Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at CeleCor Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CeleCor Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CeleCor Therapeutics, Inc.

Location

1155 CAMINO DEL MAR

Del Mar, California, United States

About

CeleCor Therapeutics is a biotechnology company on a mission to develop therapies that will get patients with a heart attack to the hospital with open coronary arteries. We focus on developing pre-hospital therapies, because early action is crucial to preserve heart muscle. The longer a coronary artery is closed, the more severe the damage to the heart. Starting treatment before patients reach the hospital, significantly improves the chances of a positive outcome. We’re developing zalunfiban; a prompt, potent, and predictable medication designed for treating patients with a heart attack before they reach the hospital. Zalunfiban has the potential to fulfil a significant unmet medical need in the pre-hospital phase of heart attack care. We’re currently running the CeleBrate trial: a pivotal Phase 3 prospective, blinded, randomized, placebo-controlled, international, multicenter, study designed to assess the safety and efficacy of a single subcutaneous injection of zalunfiban in patients with ST-segment elevation myocardial infarction in the pre-hospital setting.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CeleCor Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

2 contacts

Verified contactsMarijo, Chief Financial Officer hidden hiddenSee plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for CeleCor Therapeutics, Inc.'s next move

See what Strategic adds

CeleCor Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.